Patients with primary Merkel cell carcinoma are at an increased risk of developing a secondary skin cancer vs other malignancies.

The 'cell of origin' of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered, in a new study in mice and humans from researchers at UCL, the ...

A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Scientists at Ankara University have developed an AI tool that detects early-stage lung cancer with over 90% accuracy by ...

New data presented at AACR supports adding pembrolizumab before and after surgery in patients with newly diagnosed locally ...

Inhibrx Biosciences, Inc.’s INBX share price has dipped by 5.67%, which has investors questioning if this is right time to ...

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

Sandoz has exclusive commercial rights for a biosimilar of ipilimumab in Australia, Canada, Europe, Japan and the United ...